tradingkey.logo
tradingkey.logo
Search

Zentalis Pharmaceuticals Inc

ZNTL
Add to Watchlist
1.700USD
+0.020+1.19%
Close 11-13 16:00(ET)
160.94MMarket Cap
LossP/E TTM
After-hours 16:30 (ET)1.670USD-0.015-0.89%

Today

+1.19%

5 Days

-1.16%

1 Month

-24.11%

6 Months

-58.02%

Year to Date

+25.93%

1 Year

+27.82%

Key Figures

1.680Open
1.910High
183.95KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.19%Turnover Ratio
1.680Prev. Close
1.640Low
311.48KTurnover
LossP/E Static
0.78P/B
0.00%Div Yield TTM
-38.97%ROA
6.95052wk High
0.11Volume Ratio
-165.84MNet Profit
94.67MShares
-1.7367EPS TTM
1.98Beta
-51.93%ROE
1.28052wk Low
16.07%Amplitude
100.00%Gross Margin
160.94MMarket Cap
-3.93Reward/Risk
8.15%Risk Rate
More news coming soon, stay tuned...

Zentalis Pharmaceuticals Inc's Score

0.03vs previous score
Forecast8.36
Financial Health3.95
Technical5.20
Valuation Dimensions7.39
Institutional Confidence10.00
Risk Assessment4.15

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
7.444Target Price
+279.82%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy55222222
Buy33322222
Hold33555555
Sell00000000
Strong Sell00000000

Zentalis Pharmaceuticals Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.34/-0.54
Revenue / Forecast
--/0.00

Zentalis Pharmaceuticals Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolZNTL
Number of employees166
CountryUnited States of America

Ownership

ShareholdersProportion
Walters Group18.98%
5AM Ventures5.55%
Squadron Capital Management LLC5.17%
Two Sigma Investments, LP4.15%
Shareholder TypesProportion
Corporation20.32%
Hedge Fund20.18%
Investment Advisor16.95%
Investment Advisor/Hedge Fund11.60%

FAQs

What is the current price of Zentalis Pharmaceuticals Inc (ZNTL)?

The current price of Zentalis Pharmaceuticals Inc (ZNTL) is 1.70.

What is the symbol of Zentalis Pharmaceuticals Inc?

The ticker symbol of Zentalis Pharmaceuticals Inc is ZNTL.

What is the 52-week high of Zentalis Pharmaceuticals Inc?

The 52-week high of Zentalis Pharmaceuticals Inc is 6.95.

What is the 52-week low of Zentalis Pharmaceuticals Inc?

The 52-week low of Zentalis Pharmaceuticals Inc is 1.28.

What is the market capitalization of Zentalis Pharmaceuticals Inc?

The market capitalization of Zentalis Pharmaceuticals Inc is 160.94M.

Is Zentalis Pharmaceuticals Inc (ZNTL) currently rated as Buy, Hold, or Sell?

According to analysts, Zentalis Pharmaceuticals Inc (ZNTL) has an overall rating of Buy, with a price target of 7.44.

What is the Earnings Per Share (EPS TTM) of Zentalis Pharmaceuticals Inc (ZNTL)?

The Earnings Per Share (EPS TTM) of Zentalis Pharmaceuticals Inc (ZNTL) is -1.74.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.